CALYXHA Biotechnologies

REVOLUTION IN TARGETING TISSUE DEGENERATION

CALYXHA Biotechnologies GmbH is a biotech company developing novel therapies based on previous research at the Max Perutz Labs (University of Vienna, Vienna BioCenter Campus).

CALYXHA is developing drugs with novel mechanisms of action that address pathways involved in tissue degeneration characteristics of the most common human diseases.